Equivir/Nemovir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols sourced from natural substances which have demonstrated antiviral effects with additional potential application as health supplements or medication.

Stage: Compound development, safety, and stability are complete.

Markets: Global health supplement, antivirals

Available for worldwide licensing, joint venture, and/or co-development agreements.

Laetose technology is derived from a unique combination of sugar and inositol, which demonstrates the ability to inhibit the inflammatory and metabolic response of sugar alone.

Stage: Product development, stability, and manufacturing capability are complete.

Markets: Sugar substitute with potential to reduce calories, glycemic index, and glycemic load

Available for worldwide licensing, joint venture, and/or co-development agreements.

3F is a unique formulation of specialized ingredients from botanical sources with demonstrated effect as an insect repellent and an antimicrobial.

Stage: Contingent on regulatory approval, the three formulations have been characterized and are now available for development and/or as material additives to manufacturing processes.

Markets: Additive as fragrance, anti-microbial, repellents

Available for worldwide licensing, joint venture, and/or co-development agreements.